Novavax is a biotechnology business based in the US. Novavax stocks (NVAX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $182.72 – an increase of 23.97% over the previous week. Novavax employs 792 staff and has a trailing 12-month revenue of around $919.4 million.
How to buy Novavax stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: NVAX in this case.
- Research Novavax stocks. The platform should provide the latest information available.
- Buy your Novavax stocks. It's that simple.
What's in this guide?
- Can I buy shares in Novavax?
- Has coronavirus impacted Novavax shares?
- Novavax shares summary
- Compare share dealing platforms
- Is Novavax stock a buy or sell?
- Novavax performance over time
- Can I short Novavax shares?
- Novavax's financials
- How volatile are Novavax shares?
- Does Novavax pay a dividend?
- Have Novavax shares ever split?
- Other common questions
How has Coronavirus impacted Novavax's stock price?
Since the stock market crash in March caused by coronavirus, Novavax's stock price has had significant positive movement.
Its last market close was $183.01, which is 95.78% up on its pre-crash value of $7.72 and 2,823.48% up on the lowest point reached during the March crash when the stocks fell as low as $6.26.
If you had bought $1,000 worth of Novavax stocks at the start of February 2020, those stocks would have been worth $1,580.00 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $26,873.19.
Novavax stock priceUse our graph to track the performance of NVAX stocks over time.
Novavax stocks at a glance
|Latest market close||$183.01|
|52-week range||$76.5913 - $331.68|
|50-day moving average||$195.1856|
|200-day moving average||$194.3922|
|Wall St. target price||$271.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-8.597|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Novavax stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Novavax price performance over time
|1 month (2021-07-02)||-15.75%|
|3 months (2021-05-03)||-6.21%|
|Revenue TTM||USD$919.4 million|
|Gross profit TTM||USD$-271,429,000|
|Return on assets TTM||-25.53%|
|Return on equity TTM||-121.19%|
|Market capitalisation||USD$13.6 billion|
TTM: trailing 12 months
How to short and sell Novavax stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "NVAX.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 6.1 million Novavax stocks held short by investors – that's known as Novavax's "short interest". This figure is 0.5% down from 6.1 million last month.
There are a few different ways that this level of interest in shorting Novavax stocks can be evaluated.
Novavax's "short interest ratio" (SIR)
Novavax's "short interest ratio" (SIR) is the quantity of Novavax stocks currently shorted divided by the average quantity of Novavax stocks traded daily (recently around 4.2 million). Novavax's SIR currently stands at 1.43. In other words for every 100,000 Novavax stocks traded daily on the market, roughly 1430 stocks are currently held short.
However Novavax's short interest can also be evaluated against the total number of Novavax stocks, or, against the total number of tradable Novavax stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Novavax's short interest could be expressed as 0.08% of the outstanding stocks (for every 100,000 Novavax stocks in existence, roughly 80 stocks are currently held short) or 0.0825% of the tradable stocks (for every 100,000 tradable Novavax stocks, roughly 83 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Novavax.
Find out more about how you can short Novavax stock.
Novavax stock dividends
We're not expecting Novavax to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Have Novavax stocks ever split?
Novavax stocks were split on a 1:20 basis on 9 May 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Novavax stocks – just the quantity. However, indirectly, the new 1900% higher stock price could have impacted the market appetite for Novavax stocks which in turn could have impacted Novavax's stock price.
Novavax stock price volatility
Over the last 12 months, Novavax's stocks have ranged in value from as little as $76.5913 up to $331.68. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Novavax's is 1.5996. This would suggest that Novavax's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Stocks similar to Novavax
Novavax in the news
Doctor on COVID-19: 'People who are vaccinated are still very susceptible to infection'
What Type Of Shareholders Make Up Novavax, Inc.'s (NASDAQ:NVAX) Share Registry?
Can Last Year's Biggest Vaccine Stocks Crush the Market Again?
Frequently asked questions
More guides on Finder
How to buy Wheels Up (UP) stock in Canada when it goes public
Everything we know about the Wheels Up IPO, plus information on how to buy in.
How to buy Brookfield Asset Management Reinsurance Partners Ltd (BAMR) stock in Canada when it goes public
Everything we know about the Brookfield Asset Management Reinsurance Partners Ltd IPO, plus information on how to buy in.
How to buy Traeger (COOK) stock in Canada
Everything we know about the Traeger IPO, plus information on how to buy in.
How to buy Teads (TEAD) stock in Canada when it goes public
Everything we know about the Teads IPO, plus information on how to buy in.
How to buy Snap One Holdings Corp (SNPO) stock in Canada
Everything we know about the Snap One Holdings Corp IPO, plus information on how to buy in.
How to buy Riskified (RSKD) stock in Canada
Everything we know about the Riskified IPO, plus information on how to buy in.
How to buy Preston Hollow Community Capital (PHCC) stock in Canada when it goes public
Everything we know about the Preston Hollow Community Capital IPO, plus information on how to buy in.
How to buy PowerSchool Holdings (PWSC) stock in Canada
Everything we know about the PowerSchool Holdings IPO, plus information on how to buy in.
How to buy MeridianLink (MLNK) stock in Canada
Everything we know about the MeridianLink IPO, plus information on how to buy in.
How to buy Dole (DOLE) stock in Canada
Everything we know about the Dole IPO, plus information on how to buy in.